Biodiversity Literature Repository

Submit to community
Liberated Data
Published June 30, 2015 | Version v1
Journal article Restricted

Anti-diabetic effects of Ganoderma lucidum

Authors/Creators

  • 1. Institute of Biological Chemistry and Genomics Research Center, Academia Sinica, Taipei 115, Taiwan

Description

Ma, Haou-Tzong, Hsieh, Jung-Feng, Chen, Shui-Tein (2015): Anti-diabetic effects of Ganoderma lucidum. Phytochemistry 114: 109-113, DOI: 10.1016/j.phytochem.2015.02.017, URL: http://dx.doi.org/10.1016/j.phytochem.2015.02.017

Files

Restricted

The record is publicly accessible, but files are restricted to users with access.

Linked records

Additional details

Identifiers

LSID
urn:lsid:plazi.org:pub:FF862D70C32AFFFEFFE7FFC8044FFF99

Related works

Has part
Figure: 10.5281/zenodo.10487157 (DOI)
Figure: 10.5281/zenodo.10487159 (DOI)

References

  • Agius, L., 2007. New hepatic targets for glycaemic control in diabetes. Best practice and research. Clin. Endocrinol. Metab. 21, 587-605.
  • Batra, P., Sharma, A.K., Khajuria, R., 2013. Probing lingzhi or reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. Int. J. Med. Mushrooms 15, 127-143.
  • Bhatnagar, A., Srivastava, S.K., 1992. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem. Med. Metab. Biol. 48, 91-121.
  • Boh, B., 2013. Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs. Rec. Pat. Anti-cancer Drug Discov. 8, 255-287.
  • Boh, B., Berovic, M., Zhang, J., Zhi-Bin, L., 2007. Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol. Annu. Rev. 13, 265-301.
  • Brem, H., Tomic-Canic, M., 2007. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 117, 1219-1222.
  • Cheng, P.G., Phan, C.W., Sabaratnam, V., Abdullah, N., Abdulla, M.A., Kuppusamy, U.R., 2013. Polysaccharides-rich extract of Ganoderma lucidum (M.A. Curtis:Fr.) P. karst accelerates wound healing in streptozotocin-induced diabetic rats. J. Evidence-Based Complementary Altern. Med. 2013, 671252.
  • Cheuk, W., Chan, J.K., Nuovo, G., Chan, M.K., Fok, M., 2007. Regression of gastric large B-cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int. J. Surg. Pathol. 15, 180-186.
  • Combs, A.P., 2010. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J. Med. Chem. 53, 2333-2344.
  • Du, X.L., Sui, G.Z., Stockklauser-Farber, K., Weiss, J., Zink, S., Schwippert, B., Wu, Q.X., Tschope, D., Rosen, P., 1998. Introduction of apoptosis by high proinsulin and glucose in cultured human umbilical vein endothelial cells is mediated by reactive oxygen species. Diabetologia 41, 249-256.
  • Fatmawati, S., Kurashiki, K., Takeno, S., Kim, Y.U., Shimizu, K., Sato, M., Imaizumi, K., Takahashi,K., Kamiya,S., Kaneko,S., Kondo, R., 2009.The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum. Phytother. Res. PTR 23, 28-32.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2010a. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum. Fitoterapia 81, 1033-1036.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2010b. Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum. Planta Med. 76, 1691-1693.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2011a. Ganoderol B: a potent alpha-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine 18, 1053-1055.
  • Fatmawati, S., Shimizu, K., Kondo, R., 2011b. Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors. Bioorg. Med. Chem. Lett. 21, 7295-7297.
  • Fatmawati, S., Kondo, R., Shimizu, K., 2013. Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as alpha-glucosidase inhibitors. Bioorg. Med. Chem. Lett. 23, 5900-5903.
  • Feldhammer, M., Uetani, N., Miranda-Saavedra, D., Tremblay, M.L., 2013. PTP1B: a simple enzyme for a complex world. Crit. Rev. Biochem. Mol. Biol. 48, 430-445.
  • Gabbay, K.H., 1975. Hyperglycemia, polyol metabolism, and complications of diabetes mellitus. Annu. Rev. Med. 26, 521-536.
  • He, Z., Naruse, K., King, G., 2005. Effects of diabetes and insulin resistance on endothelial functions. In: Johnstone, M., Veves, A. (Eds.), Diabetes and Cardiovascular Diseases. Humana Press, pp. 25-46.
  • Hikino, H., Konno, C., Mirin, Y., Hayashi, T., 1985. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med. 51, 339-340.
  • Hikino, H., Ishiyama, M., Suzuki, Y., Konno, C., 1989. Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med. 55, 423-428.
  • Hsu, H.Y., Kuan, Y.C., Lin, T.Y., Tsao, S.M., Hsu, J., Ma, L.J., Sheu, F., 2013. Reishi protein LZ-8 induces FOXP3 + treg expansion via a CD45-dependent signaling pathway and alleviates acute intestinal inflammation in mice. J. Evidence-Based Complementary Altern. Med. 2013, 513542.
  • Kino, K., Yamashita, A., Yamaoka, K., Watanabe, J., Tanaka, S., Ko, K., Shimizu, K., Tsunoo, H., 1989. Isolation and characterization of a new immunomodulatory protein, Ling Zhi-8 (LZ-8), from Ganoderma lucidum. J. Biol. Chem. 264, 472-478.
  • Kino, K., Mizumoto, K., Sone, T., Yamaji, T., Watanabe, J., Yamashita, A., Yamaoka, K., Shimizu, K., Ko, K., Tsunoo, H., 1990. An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia 33, 713-718.
  • Li, F., Zhang, Y., Zhong, Z., 2011. Antihyperglycemic effect of Ganoderma lucidum polysaccharides on streptozotocin-induced diabetic mice. Int. J. Mol. Sci. 12, 6135-6145.
  • Li, P., Deng, Y.P., Wei, X.X., Xu, J.H., 2013. Triterpenoids from Ganoderma lucidum and their cytotoxic activities. Nat. Prod. Res. 27, 17-22.
  • Liu, J., Kurashiki, K., Shimizu, K., Kondo, R., 2006a. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. Biol.Pharm.Bull.29, 392-395.
  • Liu, J., Kurashiki, K., Shimizu, K., Kondo, R., 2006b. Structure-activity relationship for inhibition of 5alpha-reductase by triterpenoids isolated from Ganoderma lucidum. Bioorg. Med. Chem. 14, 8654-8660.
  • Martin, A.E., Montgomery, P.A., 1996. Acarbose: an alpha-glucosidase inhibitor. Am. J. Health-Syst. Pharm. 53, 2277-2290.
  • McCormack, J.G., Westergaard, N., Kristiansen, M., Brand, C.L., Lau, J., 2001. Pharmacological approaches to inhibit endogenous glucose production as a means of anti-diabetic therapy. Curr. Pharm. Des. 7, 1451-1474.
  • Oka, Y., Asano, T., Shibasaki, Y., Lin, J.L., Tsukuda, K., Akanuma, Y., Takaku, F., 1990. Increased liver glucose-transporter protein and mRNA in streptozocin-induced diabetic rats. Diabetes 39, 441-446.
  • Olaku, O., White, J.D., 2011. Herbal therapy use by cancer patients: a literature review on case reports. Eur. J. Cancer 47, 508-514.
  • Oliver-Krasinski, J.M., Kasner, M.T., Yang, J., Crutchlow, M.F., Rustgi, A.K., Kaestner, K.H., Stoffers, D.A., 2009. The diabetes gene Pdx1 regulates the transcriptional network of pancreatic endocrine progenitor cells in mice. J. Clin. Invest. 119, 1888-1898.
  • Pan, D., Zhang, D., Wu, J., Chen, C., Xu, Z., Yang, H., Zhou, P., 2013. Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from Ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism. PloS ONE 8, e68332.
  • Pan, D., Wang, L., Hu, B., Zhou, P., 2014. Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes. Biopolymers 101, 613-623.
  • Paterson, R.R., 2006. Ganoderma - a therapeutic fungal biofactory. Phytochemistry 67, 1985-2001.
  • Recchioni, R., Marcheselli, F., Moroni, F., Pieri, C., 2002. Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L- cysteine. Metabolism 51, 1384- 1388.
  • Schemmel, K.E., Padiyara, R.S., D'Souza, J.J., 2010. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J. Diabetes Compl. 24, 354-360.
  • Shiao, M.S., 2003. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem. Rec. 3, 172-180.
  • Sliva, D., 2006. Ganoderma lucidum in cancer research. Leuk. Res. 30, 767-768.
  • Teng, B.S., Wang, C.D., Yang, H.J., Wu, J.S., Zhang, D., Zheng, M., Fan, Z.H., Pan, D., Zhou, P., 2011. A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. J. Agric. Food Chem. 59, 6492- 6500.
  • Teng, B.S., Wang, C.D., Zhang, D., Wu, J.S., Pan, D., Pan, L.F., Yang, H.J., Zhou, P., 2012. Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. Eur. Rev. Med. Pharmacol. Sci. 16, 166-175.
  • Tie, L., Yang, H.Q., An, Y., Liu, S.Q., Han, J., Xu, Y., Hu, M., Li, W.D., Chen, A.F., Lin, Z.B., Li, X.J., 2012. Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cell. Physiol. Biochem. 29, 583-594.
  • Wachtel-Galor, S., Tomlinson, B., Benzie, I.F., 2004. Ganoderma lucidum (''Lingzhi''), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br. J. Nutr. 91, 263-269.
  • Wachtel-Galor, S., Yuen, J., Buswell, J.A., Benzie, I.F.F., 2011. Ganoderma lucidum (Lingzhi or Reishi): a medicinal mushroom. In: Benzie, I.F.F., Wachtel-Galor, S. (Eds.), Herbal Medicine: Biomolecular and Clinical Aspects, Boca Raton (FL).
  • Wu, G.S., Guo, J.J., Bao, J.L., Li, X.W., Chen, X.P., Lu, J.J., Wang, Y.T., 2013. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review. Expert Opin. Invest. Drugs 22, 981-992.
  • Xiao, C., Wu, Q.P., Cai, W., Tan, J.B., Yang, X.B., Zhang, J.M., 2012. Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice. Arch. Pharm. Res. 35, 1793-1801.
  • Zhang, H.N., He, J.H., Yuan, L., Lin, Z.B., 2003. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci. 73, 2307-2319.
  • Zheng, J., Yang, B., Yu, Y., Chen, Q., Huang, T., Li, D., 2012. Ganoderma lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting beta-cells. Comb. Chem. High Throughput Screen. 15, 542-550.